Rare diseases
Investigational molecules
Locations
Study on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis
PolandStudy on Palbociclib and Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer
PolandStudy on BI 706321 and Ustekinumab for Patients with Moderate to Severe Crohn's Disease
PolandStudy on Fenebrutinib and Teriflunomide for Adults with Relapsing Multiple Sclerosis
PolandStudy on the Safety and Effectiveness of TAK-755 (Apadamtase Alfa) for Patients with Severe Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
PolandStudy on Guselkumab for Patients with Moderate to Severe Crohn's Disease
PolandStudy on the Effects and Safety of Prasinezumab for Patients with Early Parkinson's Disease
PolandStudy on the Safety and Tolerability of Oral Dersimelagon for Patients with Erythropoietic Protoporphyria or X-Linked Protoporphyria
PolandStudy Comparing Lazertinib and Subcutaneous Amivantamab with Intravenous Amivantamab for Patients with EGFR-mutated Advanced or Metastatic Non-small Cell Lung Cancer
PolandStudy on Medical Cannabis Aerosol for Treating Diabetic Nerve Pain in Patients Using Syqe Inhaler
PolandStudy on Repotrectinib for Patients with Advanced Solid Tumors with ALK, ROS1, or NTRK1-3 Gene Changes
PolandStudy on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
